CHEKITA LEGETTE: Open Payments
NPI 1013454073 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 6 payments from 6 companies in 2025. Trend: 2023 $155 · 2024 $444 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $35 |
| Insmed, Inc. | 1 | $31 |
| La Jolla Pharmaceutical Company | 1 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: Arikayce, VIBATIV, PIFELTRO, REBYOTA.
Industry payments across SC — which companies pay providers there.
